Log in to save to my catalogue

Neuropharmacology of Antiseizure Drugs

Neuropharmacology of Antiseizure Drugs

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_24013937b62740079ad31ca2cc358800

Neuropharmacology of Antiseizure Drugs

About this item

Full title

Neuropharmacology of Antiseizure Drugs

Author / Creator

Publisher

United States: John Wiley & Sons, Inc

Journal title

Neuropsychopharmacology Reports, 2021-09, Vol.41 (3), p.336-351

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Background
Antiseizure drugs (ASDs) are the primary therapy for epilepsy, with more than 20 drugs introduced into clinical practice to date. These drugs are typically grouped by their mechanisms of action and therapeutic spectrum. This article aims to educate non‐neurologists and medical students about the new frontiers in the pharmacology of AS...

Alternative Titles

Full title

Neuropharmacology of Antiseizure Drugs

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_24013937b62740079ad31ca2cc358800

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_24013937b62740079ad31ca2cc358800

Other Identifiers

ISSN

2574-173X

E-ISSN

2574-173X

DOI

10.1002/npr2.12196

How to access this item